📰 Aditxt News
Page 2 - Aditxt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Aditxt. Real-time updates on events, politics, business and more.
April 24, 2023
Item 1.01 Entry into a Material Definitive Agreement. On April 20, 2023, Aditxt, Inc. entered into a securities purchase agreement with an institutional investor, pursuant to which the Company... | April 24, 2023
April 24, 2023
Aditxt, Inc., , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced the closing of its previously announced... | April 24, 2023
April 20, 2023
This agreement is a significant step for Aditxt as it expands its portfolio to include innovative therapies for infectious diseases; Aditxt will partner with global logistics leader Agility to... | April 20, 2023
April 20, 2023
Aditxt, Inc. , an innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system, today announced that it has entered into a definitive... | April 20, 2023
April 17, 2023
17.04.2023 - Aditxt, Inc, (NASDAQ: ADTX) (“Aditxt” or the “Company”), a global innovation company focused on therapeutics and technologies that monitor and modulate the immune system, is pleased to provide an important update regarding its three innovation ... Seite 1
April 6, 2023
Aditxt, Inc. (NASDAQ:ADTX – Get Rating)’s stock price fell 7% on Tuesday . The stock traded as low as $0.83 and last traded at $0.85. 18,404 shares traded hands during trading, a decline of 88% from the average session volume of 151,277 shares. The stock had previously closed at $0.91. Aditxt Stock Performance The firm’s […]
September 20, 2022
20.09.2022 - Aditxt, Inc., (Nasdaq: ADTX) (the “Company” or “Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public ...
July 8, 2022
08.07.2022 - Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the Company), a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune, has ... Seite 1
May 28, 2022
Aditxt, Inc. (NASDAQ:ADTX – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 724,200 shares, an increase of 79.5% from the April 30th total of 403,500 shares. Based on an average daily volume of 595,800 shares, the short-interest […]
March 3, 2022
03.03.2022 - Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AiPharma Group Ltd. to Aditxt, Inc. (“the Company”) (NasdaqCM: ADTX). Under the terms of the ...